Back
Return
Biography
Dr. Julio Aliberti

Dr. Julio Aliberti

Cincinnati Children's Hospital Medical Center, USA

 

Email: julio.aliberti@cchmc.org



Qualifications

1998  Ph.D., University of São Paulo, Brazil

1996  M.Sc., University of São Paulo, Brazil

1993  B.Sc., Barão de Mauá Faculty, Brazil

 

Publications (Selected)

  1. Machado FS, Johndrow JE, Esper L, Dias A, Bafica A, Serhan CN, Aliberti J – Anti-inflammatory actions of Lipoxin A4 and aspirin-triggered lipoxin are SOCS-2-dependent. Nature Medicine, 12:330-4, 2006.
  2. Liu CH, Fan YT, Dias A, Esper L, Corn RA, Bafica A, Machado FS, Aliberti J – Cutting Edge: Dendritic cells are essential for in vivo interleukin-12 production and development of resistance against Toxoplasma gondii infection in mice. J. Immunol., 177:31-5, 2006.
  3. Liu CH, Machado FS, Guo R, Nichols KE, Burks AW, Aliberti J, Zhong XP – Diacylglycerol kinase zeta regulates microbial recognition and host resistance to Toxoplasma gondii. J. Exp. Med., 204:781-92, 2007.
  4. Lykens JE, Terrell CE, Zoller EE, Divanovic S, Trompette A, Karp CL, Aliberti J, Flick MJ, Jordan MB. - Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo. J. Immunol. 184:877-85, 2009
  5. Zoller EE, Lykens JE, Terrell CE, Aliberti J, Filipovich AH, Henson PM, Jordan MB. Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med. 208:1203-14, 2011.